Vanguard Group’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $89.6M | Sell |
7,210,624
-168,503
| -2% | -$2.24M | ﹤0.01% | 1913 |
|
|
2025
Q3 | $106M | Sell |
7,379,127
-199,166
| -3% | -$2.73M | ﹤0.01% | 1837 |
|
|
2025
Q2 | $93M | Buy |
7,578,293
+61,665
| +0.8% | +$895K | ﹤0.01% | 1857 |
|
|
2025
Q1 | $165M | Sell |
7,516,628
-64,339
| -0.8% | -$1.51M | ﹤0.01% | 1562 |
|
|
2024
Q4 | $172M | Sell |
7,580,967
-162,961
| -2% | -$3.56M | ﹤0.01% | 1611 |
|
|
2024
Q3 | $141M | Sell |
7,743,928
-28,826
| -0.4% | -$668K | ﹤0.01% | 1722 |
|
|
2024
Q2 | $226M | Buy |
7,772,754
+791,987
| +11% | +$23.5M | ﹤0.01% | 1435 |
|
|
2024
Q1 | $247M | Sell |
6,980,767
-32,026
| -0.5% | -$1.28M | ﹤0.01% | 1384 |
|
|
2023
Q4 | $305M | Sell |
7,012,793
-147,061
| -2% | -$5.79M | 0.01% | 1275 |
|
|
2023
Q3 | $273M | Buy |
7,159,854
+72,294
| +1% | +$3.04M | 0.01% | 1266 |
|
|
2023
Q2 | $292M | Buy |
7,087,560
+62,137
| +0.9% | +$2.99M | 0.01% | 1262 |
|
|
2023
Q1 | $403M | Sell |
7,025,423
-122,336
| -2% | -$6.89M | 0.01% | 1030 |
|
|
2022
Q4 | $401M | Buy |
7,147,759
+218,153
| +3% | +$11.1M | 0.01% | 1007 |
|
|
2022
Q3 | $294M | Buy |
6,929,606
+189,772
| +3% | +$9.72M | 0.01% | 1149 |
|
|
2022
Q2 | $364M | Buy |
6,739,834
+185,727
| +3% | +$11.2M | 0.01% | 1047 |
|
|
2022
Q1 | $421M | Sell |
6,554,107
-105,015
| -2% | -$6.91M | 0.01% | 1079 |
|
|
2021
Q4 | $446M | Sell |
6,659,122
-13,264
| -0.2% | -$897K | 0.01% | 1076 |
|
|
2021
Q3 | $457M | Buy |
6,672,386
+20,888
| +0.3% | +$1.48M | 0.01% | 1030 |
|
|
2021
Q2 | $454M | Buy |
6,651,498
+44,050
| +0.7% | +$3.12M | 0.01% | 1059 |
|
|
2021
Q1 | $457M | Buy |
6,607,448
+132,907
| +2% | +$9M | 0.01% | 1011 |
|
|
2020
Q4 | $420M | Buy |
6,474,541
+93,571
| +1% | +$5.04M | 0.01% | 971 |
|
|
2020
Q3 | $301M | Sell |
6,380,970
-301,688
| -5% | -$14.4M | 0.01% | 1014 |
|
|
2020
Q2 | $314M | Sell |
6,682,658
-150,929
| -2% | -$7.42M | 0.01% | 997 |
|
|
2020
Q1 | $305M | Buy |
6,833,587
+182,888
| +3% | +$9.6M | 0.01% | 887 |
|
|
2019
Q4 | $388M | Sell |
6,650,699
-143,184
| -2% | -$8.52M | 0.01% | 969 |
|
|
2019
Q3 | $408M | Buy |
6,793,883
+354,746
| +6% | +$21.1M | 0.02% | 896 |
|
|
2019
Q2 | $360M | Buy |
6,439,137
+144,122
| +2% | +$7.42M | 0.01% | 990 |
|
|
2019
Q1 | $351M | Buy |
6,295,015
+93,205
| +2% | +$4.75M | 0.01% | 981 |
|
|
2018
Q4 | $280M | Buy |
6,201,810
+82,621
| +1% | +$4.53M | 0.01% | 1028 |
|
|
2018
Q3 | $403M | Sell |
6,119,189
-173,390
| -3% | -$10.8M | 0.02% | 904 |
|
|
2018
Q2 | $405M | Buy |
6,292,579
+295,706
| +5% | +$18.3M | 0.02% | 891 |
|
|
2018
Q1 | $332M | Buy |
5,996,873
+97,751
| +2% | +$5.12M | 0.01% | 969 |
|
|
2017
Q4 | $282M | Buy |
5,899,122
+220,432
| +4% | +$10.8M | 0.01% | 1066 |
|
|
2017
Q3 | $287M | Buy |
5,678,690
+183,796
| +3% | +$9.44M | 0.01% | 1030 |
|
|
2017
Q2 | $300M | Sell |
5,494,894
-161,154
| -3% | -$7.7M | 0.01% | 979 |
|
|
2017
Q1 | $238M | Buy |
5,656,048
+436,928
| +8% | +$18.7M | 0.01% | 1100 |
|
|
2016
Q4 | $224M | Buy |
5,219,120
+178,214
| +4% | +$7.24M | 0.01% | 1096 |
|
|
2016
Q3 | $208M | Buy |
5,040,906
+224,904
| +5% | +$9.42M | 0.01% | 1082 |
|
|
2016
Q2 | $192M | Buy |
4,816,002
+267,550
| +6% | +$9.63M | 0.01% | 1079 |
|
|
2016
Q1 | $153M | Buy |
4,548,452
+122,328
| +3% | +$3.81M | 0.01% | 1183 |
|
|
2015
Q4 | $150M | Buy |
4,426,124
+118,854
| +3% | +$3.72M | 0.01% | 1181 |
|
|
2015
Q3 | $128M | Sell |
4,307,270
-336,704
| -7% | -$10.5M | 0.01% | 1270 |
|
|
2015
Q2 | $128M | Buy |
4,643,974
+434,927
| +10% | +$11.6M | 0.01% | 1363 |
|
|
2015
Q1 | $106M | Buy |
4,209,047
+239,683
| +6% | +$5.67M | 0.01% | 1455 |
|
|
2014
Q4 | $88M | Buy |
3,969,364
+106,113
| +3% | +$2.15M | 0.01% | 1507 |
|
|
2014
Q3 | $78.4M | Buy |
3,863,251
+77,093
| +2% | +$1.53M | 0.01% | 1527 |
|
|
2014
Q2 | $72.8M | Buy |
3,786,158
+92,661
| +3% | +$1.73M | 0.01% | 1618 |
|
|
2014
Q1 | $69.4M | Buy |
3,693,497
+197,706
| +6% | +$3.82M | 0.01% | 1606 |
|
|
2013
Q4 | $68.2M | Buy |
3,495,791
+486,824
| +16% | +$8.93M | 0.01% | 1583 |
|
|
2013
Q3 | $49.5M | Buy |
3,008,967
+126,815
| +4% | +$2.03M | ﹤0.01% | 1725 |
|
|
2013
Q2 | $43.2M | Buy |
+2,882,152
| New | +$42.2M | ﹤0.01% | 1726 |
|
Other funds holding IART
RCMNY
PCMI
Vanguard Group's IART Position: Q4 2025 in Review
Vanguard Group reduced its Integra LifeSciences (IART) stake by 2.3% in Q4 2025, selling an estimated $2.24M and leaving 7,210,624 shares worth $89.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1913.
Vanguard Group first reported a position in IART in Q2 2013 and has held it in 51 quarters since. The position peaked at $457M in Q3 2021. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.
- Vanguard Group held 7,210,624 shares of Integra LifeSciences worth $89.6M as of Q4 2025.
- Vanguard Group sold 168,503 Integra LifeSciences shares in Q4 2025, an estimated $2.24M.
- Integra LifeSciences made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1913 holding.
- Vanguard Group first reported a position in Integra LifeSciences in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Integra LifeSciences position peaked at $457M in Q3 2021.
- 204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.